ROBERT BRITTON to Drug Design
This is a "connection" page, showing publications ROBERT BRITTON has written about Drug Design.
Connection Strength
0.161
-
Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*. ChemMedChem. 2021 04 08; 16(7):1116-1125.
Score: 0.161